Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-04-01
2000-03-21
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514213, 514215, 514922, 514970, 514973, 514994, A01N 4346, A61K 3155
Patent
active
060403012
ABSTRACT:
For the oral administration of the anti-depressant mirtazapine an aqueous solution or suspension is found which is preferably stabilized by methionine, is thickened, and which has a pH of from 2.5 to 3. By the formulation according to the invention, an undesirable local anesthetic effect of mirtazapine is avoided.
REFERENCES:
patent: 4062848 (1977-12-01), van der Burg
patent: 5208261 (1993-05-01), Van Den Oetelaar et al.
patent: 5238688 (1993-08-01), Beuving et al.
Davis R et al., Mirtazapine A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression, vol. 5, No. 2, May 1, 1996,. pp. 389-402.
Mattila M et al., Actions and Interactions of Psychotropic Drugs on Human Performance and Mood: Single Doses or Org 3770, Amitriptyline, and Diazepam, Pharmacology and Toxicology, vol. 65, No. 2, Aug. 1, 1989, pp. 81-88.
Skrabanja Arnold Titus Philip
Tully Robert Edward
Akzo Nobel N.V.
Gormley Mary E.
Krass Frederick
LandOfFree
Oral liquid antidepressant solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral liquid antidepressant solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral liquid antidepressant solution will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730490